Abeona Therapeutics Inc.
(ABEO - NASDAQ)
5,34 USD
📋 Profilo Aziendale

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases.

|